Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anticoagulants vs aspirin and clopidogrel in ischemic stroke
IRCT20221026056307N1Phase 3Completed
- Sponsor
- North Khorasan University of Medical Sciences
- Start
- Feb 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aspirin and clopidogrel in ischemic stroke and brain infarction (3 arms), sponsored by North Khorasan University of Medical Sciences. Started Feb 2023; status: completed.
02
Drugs
aspirinclopidogrel
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on IRCT20221026056307N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221026056307N1.